Screen KIT nCoV-2/QUANTICOR
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
Hiantis
Milan, Lombardy, Italyhiantis.it ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Hiantis has developed CE-marked in vitro diagnostic devices, including the Screen KIT nCoV‑2/QUANTICOR for coronavirus detection and quantification. The company previously licensed a pharmaceutical formulation patent for osteoporosis to an Italian pharma company. It has participated in EU-funded projects on HPV diagnostics and is involved in biomarker validation platforms.
- Therapeutic areas
- OncologyEndocrinologyInfectious Diseases
- Modalities
- In vitro diagnostic deviceSmall molecule
- Industry
- Molecular Diagnostics
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Genefirst (UK) – Horizon 2020 project on HPV diagnosticsBBMRI.it Expert Centre – biomarker verification platform participationCopan S.p.A., Lutech S.p.A., Universities of Milano & Milano-Bicocca, ASSTs Bergamo & Monza – regional viral emergency response collaboration
Beyond the preview
Go deeper on Hiantis.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hiantis.